BACKGROUND: Microbial contamination of ready-to-eat foods and beverages sold by street vendors and hawkers has become an important public health issue. In Ethiopia, health risks related to such kinds of foods are thought to be common. Thus, this study has tried to determine the bacteriological quality of ready-to-eat foods sold on streets. METHODS: A cross-sectional study was conducted on street foods in Hawassa City from May to September 2014. A total of 72 samples from six food items such as local bread ('ambasha' and'kita'), raw fish, chilli ('awaze'), avocado and cooked potato were collected. Bacterial isolation, colony count and antimicrobial susceptibility testing were made following standard microbiological techniques. RESULTS: About 31% of the food samples showed total colony counts ranging from 1.7x10 5 to 6.7x10 6 colony-forming unit per gram (CFU/g) which is beyond the acceptable limits set for microbiological quality of ready-to -eat foods. The mean coliform and Enterobacteriaceae counts in raw fish, 'kita' and 'ambasha' were also higher than the limits. E.coli was the most frequent isolate (29.6%) followed by Salmonella species (12.7% and S.aureus (9.9%). All isolates were 100% sensitive to ciprofloxacin. About 89% of Salmonella sp was resistant to chloramphenicol. Alarmingly, 14.3% of S.aureus was resistant to vancomycin. CONCLUSION: This study confirmed considerable rate of contamination in street vended foods in Hawassa City. The identified foodborne bacteria and antibiotic resistance isolates could pose a public health problem in that locality. Therefore, regular inspection, health education and training of vendors on food handling and safety practices are recommended.

Pediatric human immunodeficiency virus (HIV) care in resource-limited settings remains a major challenge to achieving global HIV treatment and virologic suppression targets, in part because the administration of combination antiretroviral therapies (cART) is inherently complex in this population and because viral load and drug resistance genotyping are not routinely available in these settings. Children may also be at elevated risk of transmission of drug-resistant HIV as a result of suboptimal antiretroviral administration for prevention of mother-to-child transmission. We investigated the prevalence and the correlates of pretreatment HIV drug resistance (PDR) among HIV-infected, cART-naive children in Ethiopia. We observed an overall PDR rate of 14%, where all cases featured resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs): ~9% of participants harbored resistance solely to NNRTIs while ~5% harbored resistance to both NNRTIs and nucleoside reverse transcriptase inhibitors (NRTIs). No resistance to protease inhibitors was observed. No sociodemographic or clinical parameters were significantly associated with PDR, though limited statistical power is noted. The relatively high (14%) rate of NNRTI resistance in cART-naive children supports the use of non-NNRTI-based regimens in first-line pediatric treatment in Ethiopia and underscores the urgent need for access to additional antiretroviral classes in resource-limited settings.